Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast.
The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...
Yahoo Finance29d
Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs
Hims & Hers ... its weight-loss business to generate at least $725 million in 2025. The company already offers monthly subscription for popular GLP-1 diabetes and weight-loss drugs Ozempic ...
MarketWatch29d
Hims & Hers Health Shares Tumble as its Weight-Loss Treatments Face Tough Environment
Shares of Hims & Hers Health dropped 22% in premarket trading ... a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. The company last year began ...
AOL29d
Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs
Hims & Hers (HIMS) stock plunged 27% on Tuesday after the telehealth highflier indicated it may soon stop offering some compounded versions of weight-loss drugs. The company's fourth quarter ...